FEMSelect

Surgical Devices · Newark, DE · Founded 2012 · Privately Held (backing)

Developer of medical devices designed to treat pelvic organ prolapse disease in women. FEMSelect is based in Newark, DE and was founded in 2012. It was valued at $17 million at its later-stage round in Sep 2022, the last priced event on record. It has raised $12.2 million across 1 recorded round; the latest was an accelerator round in Jan 2018.

PMV mark · valuation
$17.0M
Oct 2026
Priced at
its later-stage round
Sep 2022
Total raised
$12.2M
Last round
Accelerator/Incubator
Jan 2018
How much has FEMSelect raised?
$12.2Macross 1 recorded rounds · Jan 2018 – Jan 2018

Most recently, FEMSelect raised an undisclosed amount in its Accelerator/Incubator (Jan 2018).

Free account
More of FEMSelect with a free account
  • ·The complete investor list: 21 names
  • ·Watch FEMSelect: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

FEMSelect round by round

1 rounds
Jan 2018Accelerator/Incubatorundisclosed▮
+ 1 more investors · free account

How much has FEMSelect raised?

FEMSelect has raised $12.2 million in total; 1 of its rounds is on record. The most recent was an accelerator round in Jan 2018.

FEMSelect investors

21 investors are on record for FEMSelect, including Springboard Enterprises, Keiretsu Forum, Innovation Authority and New York Angels.

For fundraisers
Raising for a company like FEMSelect?

21 investors have backed FEMSelect — start your target list with the firms already writing checks in surgical devices.

See all 21 investors →

Frequently asked about FEMSelect

How much has FEMSelect raised?
FEMSelect has raised $12.2M in total across 1 recorded funding rounds.
When was FEMSelect's last funding round?
FEMSelect's most recent recorded round was Accelerator/Incubator in Jan 2018.